← Eichor
Study identifier: NCT07050095 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Condition: Anxiolytic Effect · Virtual Reality Immersion · Midazolam  ·  Sponsor: Cairo University

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.

This description comes directly from the study's public registry record.

Talk to the study team

Hebatullah S Abdelhamid, MD  ·  002 01044512277  ·  drhebasalah593@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo UniversityCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07050095